» Articles » PMID: 25120544

The Intercellular Metabolic Interplay Between Tumor and Immune Cells

Overview
Journal Front Immunol
Date 2014 Aug 15
PMID 25120544
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Functional and effective immune response requires a metabolic rewiring of immune cells to meet their energetic and anabolic demands. Beyond this, the availability of extracellular and intracellular metabolites may serve as metabolic signals interconnecting with cellular signaling events to influence cellular fate and immunological function. As such, tumor microenvironment represents a dramatic example of metabolic derangement, where the highly metabolic demanding tumor cells may compromise the function of some immune cells by competing nutrients (a form of intercellular competition), meanwhile may support the function of other immune cells by forming a metabolic symbiosis (a form of intercellular collaboration). It has been well known that tumor cells harness immune system through information exchanges that are largely attributed to soluble protein factors and intercellular junctions. In this review, we will discuss recent advance on tumor metabolism and immune metabolism, as well as provide examples of metabolic communications between tumor cells and immune system, which may represent a novel mechanism of conveying tumor-immune privilege.

Citing Articles

ASPiring metabolic-immunotherapy by ASParaginase.

Shah R, Wang R Nat Metab. 2025; .

PMID: 40045117 DOI: 10.1038/s42255-025-01241-w.


Integrated Analysis of Phagocytic and Immunomodulatory Markers in Cervical Cancer Reveals Constellations of Potential Prognostic Relevance.

Yordanov A, Damyanova P, Vasileva-Slaveva M, Hasan I, Kostov S, Shivarov V Int J Mol Sci. 2024; 25(16).

PMID: 39201801 PMC: 11354974. DOI: 10.3390/ijms25169117.


Angiogenesis Still Plays a Crucial Role in Human Melanoma Progression.

Cazzato G, Ingravallo G, Ribatti D Cancers (Basel). 2024; 16(10).

PMID: 38791873 PMC: 11120419. DOI: 10.3390/cancers16101794.


Critical role of the gut microbiota in immune responses and cancer immunotherapy.

Li Z, Xiong W, Liang Z, Wang J, Zeng Z, Kolat D J Hematol Oncol. 2024; 17(1):33.

PMID: 38745196 PMC: 11094969. DOI: 10.1186/s13045-024-01541-w.


Selective refueling of CAR T cells using ADA1 and CD26 boosts antitumor immunity.

Hu Y, Sarkar A, Song K, Michael S, Hook M, Wang R Cell Rep Med. 2024; 5(5):101530.

PMID: 38688275 PMC: 11148642. DOI: 10.1016/j.xcrm.2024.101530.


References
1.
Roodhart J, Daenen L, Stigter E, Prins H, Gerrits J, Houthuijzen J . Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids. Cancer Cell. 2011; 20(3):370-83. DOI: 10.1016/j.ccr.2011.08.010. View

2.
Wahl L, Kleinman H . Tumor-associated macrophages as targets for cancer therapy. J Natl Cancer Inst. 1998; 90(21):1583-4. DOI: 10.1093/jnci/90.21.1583. View

3.
Gordon S . Alternative activation of macrophages. Nat Rev Immunol. 2003; 3(1):23-35. DOI: 10.1038/nri978. View

4.
June C . Adoptive T cell therapy for cancer in the clinic. J Clin Invest. 2007; 117(6):1466-76. PMC: 1878537. DOI: 10.1172/JCI32446. View

5.
Franklin R, Liao W, Sarkar A, Kim M, Bivona M, Liu K . The cellular and molecular origin of tumor-associated macrophages. Science. 2014; 344(6186):921-5. PMC: 4204732. DOI: 10.1126/science.1252510. View